Literature DB >> 9626140

Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons.

Z A Erkut1, C Pool, D F Swaab.   

Abstract

Glucocorticoids are widely used in clinical practice in a variety of immune-mediated and neoplastic diseases, mostly for their immunosuppressive, leukopenic, antiedematous, or malignancy-suppressive actions. However, their usage is limited because of serious and sometimes life-threatening side-effects. Endogenous glucocorticoids are secreted by the adrenal cortex under the control of the hypothalamus and the pituitary gland. This hypothalamo-pituitary-adrenal axis, in turn, is under the negative feedback control of glucocorticoids. Although the suppression of adrenocortical and pituitary gland functions by glucocorticoids has been shown in humans, a feedback effect at the level of the hypothalamus, as shown in rat, has not been reported to date. The present study shows for the first time that glucocorticoids suppress both CRH and vasopressin (AVP) in the human hypothalamus. We studied immunocytochemically the postmortem hypothalami of nine corticosteroid-exposed subjects and eight controls. The number of CRH-expressing cells in the hypothalamic paraventricular nucleus of glucocorticoid-exposed patients was only 3.3% of that in the controls, and the total immunoreactivities for AVP were 31% and 33% of that in the controls in the supraoptic nucleus and the paraventricular nucleus, respectively, whereas the immunoreactivity for oxytocin did not differ between the two groups. Suppression of hypothalamic CRH and AVP neurons by glucocorticoids may have important consequences for neuroendocrinological mechanisms such as the disturbance of water balance during the treatment as well as the immunological processes in the brain and the pathogenesis of the withdrawal syndrome after discontinuation of corticosteroid treatment. In addition, as both AVP and CRH neurons also project to other brain structures and influence memory, mood, and behavior, their suppression by glucocorticoids may be responsible for at least part of the central nervous system side-effects of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626140     DOI: 10.1210/jcem.83.6.4881

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Endocrinopathy-induced euvolemic hyponatremia.

Authors:  Talia Diker-Cohen; Benaya Rozen-Zvi; Dana Yelin; Amit Akirov; Eyal Robenshtok; Anat Gafter-Gvili; Daniel Shepshelovich
Journal:  Intern Emerg Med       Date:  2018-05-22       Impact factor: 3.397

2.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

4.  Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit.

Authors:  Dragana Miljic; Mirjana Doknic; Marko Stojanovic; Marina Nikolic-Djurovic; Milan Petakov; Vera Popovic; Sandra Pekic
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

5.  Hyponatremia and seizures caused by triamcinolone-induced adrenal insufficiency.

Authors:  Stefan Reuter; Niklas Scholten; Hermann Pavenstädt; Uta Hillebrand; Eckhart Büssemaker
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

6.  Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation.

Authors:  M M Sánchez; L J Young; P M Plotsky; T R Insel
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

7.  The long-term effects of rapamycin-based immunosuppressive protocols on the expression of renal aquaporins 1, 2, 3 and 4 water channels in rats.

Authors:  Marta Grabowska; Katarzyna Michałek; Karolina Kędzierska-Kapuza; Andrzej Kram; Kamil Gill; Małgorzata Piasecka
Journal:  Histol Histopathol       Date:  2021-02-26       Impact factor: 2.303

8.  Binge-pattern alcohol exposure during puberty induces sexually dimorphic changes in genes regulating the HPA axis.

Authors:  Magdalena M Przybycien-Szymanska; Yathindar S Rao; Toni R Pak
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-01       Impact factor: 4.310

9.  Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.

Authors:  Aju Abraham; Stuart Watson; Allan H Young
Journal:  Indian J Psychiatry       Date:  2003-04       Impact factor: 1.759

10.  Arginine vasopressin regulation in pre- and postpubertal male rats by the androgen metabolite 3beta-diol.

Authors:  Toni R Pak; Wilson C J Chung; Laura R Hinds; Robert J Handa
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-21       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.